Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemzar, Novantrone, and Rituxan in Relapsed/Refractory MCL
NCT00656084Phase 2Completed
- Sponsor
- US Oncology Network
- Start
- Dec 2004
- Primary completion
- Jan 2007
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of gemcitabine in mantle cell lymphoma (MCL), sponsored by US Oncology Network. Started Dec 2004; status: completed.
02
Drugs
gemcitabine
03
Conditions
mantle cell lymphoma (MCL)
Beyond the preview
Go deeper on NCT00656084.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00656084.